Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brian Evans

Plastic Surgery West Hills, CA Medical Doctor

NPI 1932159977 CMS profile 731782

7325 Medical Center Dr Ste 304, West Hills, CA 91307

Open in the dashboard

General payments

$41,079

144 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Brian Evans of West Hills, CA is reported in the CMS Open Payments database as having received $41,079 across 144 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $312 6
2024 General $23,643 24
2023 General $1,496 26
2022 General $846 17
2021 General $862 26
2020 General $2,935 11
2019 General $10,986 34

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brian Evans
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Brian Evans were reported at $312. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Brian Evans Plastic Surgery median Middle half National median
2019 $10,986 $371 $122–$1,483 $163
2020 $2,935 $158 $52–$438 $114
2021 $862 $249 $87–$752 $132
2022 $846 $274 $102–$793 $149
2023 $1,496 $299 $113–$891 $160
2024 $23,643 $361 $124–$1,062 $164
2025 $312 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. PolyNovo North America LLC $24,195 29 payments
  2. Kerecis Limited $12,299 8 payments
  3. KCI USA, Inc $967 4 payments
  4. Smith+Nephew, Inc. $819 27 payments
  5. Aroa Biosurgery Incorporated $504 12 payments
  6. Sanara MedTech Inc. $305 3 payments
  7. Integra LifeSciences Corporation $285 14 payments
  8. Next Science LLC $234 4 payments
  9. Acera Surgical, Inc. $174 4 payments
  10. TissueTech, Inc. $166 2 payments
  11. Other $1,130 37 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $21,281 5 payments
  2. Food and Beverage $8,982 133 payments
  3. Travel and Lodging $6,585 4 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,231 2 payments
Products named General payments · program years 2019–2025
  1. NOVOSORB BTM $23,265 16 payments
  2. Kerecis Omega3 Wound $11,953 6 payments
  3. KERRACONTACT AG (US) $800 1 payment
  4. CellerateRx $305 3 payments
  5. Kerecis Omega3 SurgiClose Wound Care $298 1 payment
  6. Kerecis Omega3 SurgiClose Wound Care $298 1 payment
  7. Kerecis Omega3 SurgiClose Wound Care $298 1 payment
  8. Kerecis Omega3 GraftGuide $298 1 payment
  9. Kerecis Omega3 Marigen $298 1 payment
  10. GRAFIX PL $248 7 payments
  11. Other $4,730 163 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 70 billing codes

Paid by Medicare

$548,602

Of which drugs: $379,124

Medicare patients

244

Average age 78

Services billed

2,456

122 women, 122 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Arthritis 61%
Diabetes 59%
Heart failure 56%
Chronic kidney disease 51%
Atrial fibrillation 48%
Depression 48%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

144 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record